Sofwave is the latest innovative technology to revitalize skin by stimulating collagen growth
While injectables generally yield greater weight loss, oral alternatives offer the convenience of daily use
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
For a crunchier, grab-and-go option, I like The Only Bean Crunchy Roasted Edamame
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity